EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Application of type I and II error analysis to support economic decision-making of using an immunomodulator feed additive

L T Casarotto, A De Vries, J D Chapman, L O Ely, G E Dahl

Journal of Dairy Science · 2024

DOI: 10.3168/jds.2024-25105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Dairy Science, 2024. Verfasst von L T Casarotto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Sciences, University of Florida, Gainesville, FL 32611. Hauptthemen laut MEDLINE: Milk, Dietary Supplements, Animal Feed, Lactation. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of the immunomodulator OmniGen-AF (OMN) feed supplement, where the response in milk yield, health, and reproduction is uncertain, allows for an application of type I (use the product when it is not profitable) and type II (do not use the product when it is profitable) analysis to aid decision-making regarding its profitability. This study applies a type I and II error analysis to quantify the economic risk of investing in OMN feed supplementation using data from a controlled study and a field dataset collected on dairy farms. Four prediction models were applied considering the expected value and SD of the response in milk yield; milk and health; milk and reproduction; and milk, health, and reproduction. Uncertainty in the milk response was modeled following a normal distribution with mean 0.15 kg/cow per day and SD 0.81 kg/cow per day. This distribution was left-truncated at 0 kg, which resulted in a mean (expected) response of 0.7 kg/cow per day. Based on the field dataset, the reduction in health costs and reproduction were estimated at $0.086 and $0.33/cow per day. All 3 responses were assumed to be present or not in the first 90 DIM. The increase in milk yields necessary to pay for the OMN supplementation considering a response in milk yield only; milk and health; milk and reproduction; and milk, health, and reproduction were 0.45, 0.19, -0.56, and -0.82 kg/cow per day, respectively. The break-even OMN cost per cow per day when considering the increases in milk yield; milk and health; milk and reproduction; and milk, health, and reproduction were $0.23, $0.31, $0.56, and $0.65, respectively. Production responses resulted in costs exceeding revenue with a type I error cost of $2.62 for milk and $0.47 for milk and health response for the broke even. There was no type I error cost associated when considering the responses in milk and reproduction, and the combination of milk, health, and reproduction, which implies that there is no risk of using OMN when it is not profitable (= the product is profitable for certain). Type II costs were associated with returns that are unrealized because of failing to use OMN when it is profitable with an opportunity cost of $9.92, $15.53, $37.23, and $45.08 per cow per day for the responses in milk yield; milk and health; milk and reproduction; and milk, health, and reproduction, respectively. We concluded that a type I and II error analysis applied to the use of the OMN feed additive provided additional insights beyond a break-even analysis to support economic decision-making when the response on dairy farms is uncertain. The type I and II error analysis can aid in decision-making process to evaluate the adoption of a new technology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MilkDietary SupplementsAnimal FeedLactationAnimalsCattleFemaleDecision MakingDietImmunomodulating Agents

Stichwörter der Autor:innen

dairy economicshealthmilkreproduction

Substanzen

Immunomodulating Agents

Autor:innen und Institutionen

  • Department of Animal Sciences, University of Florida, Gainesville, FL 32611.
  • Phibro Animal Health Corporation, Teaneck, NJ 07666.
  • Department of Animal and Dairy Science, University of Georgia, Athens, GA 30602.
  • Department of Animal Sciences, University of Florida, Gainesville, FL 32611. Electronic address: gdahl@ufl.edu.

Zitieren

APA

Casarotto, L. T., De Vries, A., Chapman, J. D., Ely, L. O., & Dahl, G. E. (2024). Application of type I and II error analysis to support economic decision-making of using an immunomodulator feed additive. Journal of Dairy Science. https://doi.org/10.3168/jds.2024-25105

Vancouver

Casarotto LT, De Vries A, Chapman JD, Ely LO, Dahl GE. Application of type I and II error analysis to support economic decision-making of using an immunomodulator feed additive. Journal of Dairy Science. 2024. doi:10.3168/jds.2024-25105

BibTeX
@article{Casarotto2024,
  author = {Casarotto, L T and De Vries, A and Chapman, J D and Ely, L O and Dahl, G E},
  title = {Application of type I and II error analysis to support economic decision-making of using an immunomodulator feed additive},
  journal = {Journal of Dairy Science},
  year = {2024},
  doi = {10.3168/jds.2024-25105}
}
Kostenlos starten →